Christopher Robinson has repeatedly been recognized by his peers and clients alike as a leading expert in patent procurement in the life sciences and related industries. He has been practicing in this area for over 25 years, representing innovative biotechnology and chemical companies, with a particular emphasis on biologics and pharmaceuticals, and agricultural technologies.
He has extensive expertise with every facet of the patent procurement process and also provides strategic advice on portfolio management and licensing. His practice is diverse, including molecular biology, peptide chemistry, immunology and genetics based innovation. He has broad experience in patenting antibodies, vaccines, enzymes for use in the life sciences and industrial biotechnology, stem cells, gene therapy, and medical diagnostics. He assists clients in advising them on enforcement, including under the Patented Medicines (Notice of Compliance) Regulations, and commercialization in Canada.
Christopher also has extensive experience in trademark prosecution, opposition and enforcement, particularly in the food, beverage, and pharmaceutical industries.
Christopher works with clients ranging from small and medium-sized life sciences and pharmaceutical companies to multinational corporations, and he also has experience working with universities. He manages global patent portfolios for his Canadian client base, and has been entrusted with protecting new innovation in Canada for many of the world’s leading chemical and biotechnology companies. Clients and colleagues have referred to Christopher is a “life sciences maven” who brings a quarter-century’s patent procurement experience to the table (IAM Patents 1000, 2017).
Christopher is also a teacher, developing not only associates within the firm, but also educating new intellectual property leaders through university patent law classes and programs provided by the Intellectual Property Institute of Canada.